International audienceBecause only a minority of patients with nonalcoholic fatty liver disease (NAFLD) have advanced fibrosis and would eventually develop liver-related complications, current guidelines recommend initial assessment with noninvasive tests of fibrosis.1-3 Most previous studies focused on overweight and obese patients. Despite a strong association between obesity and NAFLD, 3%-30% of people with relatively normal body mass index (BMI) may still have NAFLD.4,5 Hence, this study aims to evaluate the performance of the common noninvasive tests in non-obese (BMI <25 kg/m2) and obese (BMI ≥25 kg/m2) NAFLD patients
FIBROSIS DIAGNOSTIC SCORES VALIDATION IN OBESE PATIENTS WITH NON-ALCOHOLIC LIVER DISEAS
Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic fatt...
Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20-25% of the general population and is ass...
Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20–25% of the general population and is ass...
Non-Alcoholic Fatty Liver Disease (NAFLD) affects more than 90% of patients with morbid obesity (MO)...
It remains unclear whether screening for advanced fibrosis in the community can identify the subgrou...
PURPOSE: In morbid obesity nonalcoholic fatty liver disease (NAFLD) is endemic. Aim of this study is...
BackgroundNon-alcoholic fatty liver disease (NAFLD) is a frequent condition in obese patients and re...
Background. Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of diseases associated with...
Background In nonalcoholic fatty liver disease (NAFLD), advanced fibrosis has been identified as ...
Background: Nonalcoholic Fatty Livery Disease (NAFLD) affects a large population in the US, with sig...
Background & Aims: Noninvasive assessment of histological features of nonalcoholic fatty liver disea...
Aims :To compare the NAFLD fibrosis score and FIBROSIS 4 score to fibroscan, and affirm whether the ...
Background. Bariatric surgery patients have a higher prevalence of nonalcoholic fatty liver (NAFL) t...
More than 90% of patients with Morbid Obesity (MO) have Non-Alcoholic Fatty Liver Disease, complicat...
FIBROSIS DIAGNOSTIC SCORES VALIDATION IN OBESE PATIENTS WITH NON-ALCOHOLIC LIVER DISEAS
Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic fatt...
Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20-25% of the general population and is ass...
Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20–25% of the general population and is ass...
Non-Alcoholic Fatty Liver Disease (NAFLD) affects more than 90% of patients with morbid obesity (MO)...
It remains unclear whether screening for advanced fibrosis in the community can identify the subgrou...
PURPOSE: In morbid obesity nonalcoholic fatty liver disease (NAFLD) is endemic. Aim of this study is...
BackgroundNon-alcoholic fatty liver disease (NAFLD) is a frequent condition in obese patients and re...
Background. Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of diseases associated with...
Background In nonalcoholic fatty liver disease (NAFLD), advanced fibrosis has been identified as ...
Background: Nonalcoholic Fatty Livery Disease (NAFLD) affects a large population in the US, with sig...
Background & Aims: Noninvasive assessment of histological features of nonalcoholic fatty liver disea...
Aims :To compare the NAFLD fibrosis score and FIBROSIS 4 score to fibroscan, and affirm whether the ...
Background. Bariatric surgery patients have a higher prevalence of nonalcoholic fatty liver (NAFL) t...
More than 90% of patients with Morbid Obesity (MO) have Non-Alcoholic Fatty Liver Disease, complicat...
FIBROSIS DIAGNOSTIC SCORES VALIDATION IN OBESE PATIENTS WITH NON-ALCOHOLIC LIVER DISEAS
Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic fatt...
Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20-25% of the general population and is ass...